Biotechnology
September 08, 2016
EpiPen Pricing: Much Ado About Nothing Drug prices are back in the news, this time focused on the epinephrine auto-injector marketed by Mylan [NASDAQ: MYL] as “EpiPen.” EpiPen is a life-saving product for those at risk of anaphylaxis — a severe allergic reaction which in different individuals can be Read more…